HLX18

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX18, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors [Phase 1]